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Abstract Cardiomyocyte apoptosis and cardiac fibroblast
proliferation are characteristic features of failing myocardium.
Here we investigated the effect of superoxide on the cell fate of
cardiomyocytes and cardiac fibroblasts. Cultured rat cardio-
myocytes or cardiac fibroblasts were treated with superoxide. In
response to superoxide stimulation cardiomyocytes underwent
apoptosis as revealed by the increase in histone associated DNA
fragmentation and positive to in situ nick end-labeling. In
contrast, cardiac fibroblasts were stimulated to proliferate as
demonstrated by the increase in DNA synthesis detected by
[3H]thymidine incorporation and in cell number. Additionally,
Northern blot analysis showed that transforming growth factor-
L1, a key factor responsible for myocardial fibrosis, was
upregulated in cardiac fibroblasts in response to superoxide
stimulation. These data suggest that superoxide can induce such
divergent effects as apoptosis in cardiomyocytes and cell growth
in cardiac fibroblasts, indicating that it may be a potential factor
involved in the pathogenesis of heart failure.
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1. Introduction
Cardiomyocyte apoptosis has been observed in heart dis-
eases such as dilated cardiomyopathy, ischemic cardiomyop-
athy, acute myocardial infarction, and cardiac allograft rejec-
tion (for review see [1]). Patients a¥icted with these diseases
have a poor prognosis due to the development of congestive
heart failure. Interestingly, there is increasing evidence indi-
cating that oxidative stress is related to heart failure [2,3].
However, it remains to be determined which type of ROS is
involved in heart failure. Since there is evidence showing that
mice lacking manganese superoxide dismutase die with a di-
lated cardiomyopathy [4,5], we hypothesized that superoxide
(O32 ) might be a potential candidate.
In the chronic state failing myocardium is characterized by
loss of cardiomyocytes and extensive ¢brosis. The latter of
which may be related to the action of transforming growth
factor-L1 (TGF-L1), because TGF-L1 stimulates the synthesis
of extracellular matrix components such as collagen, ¢bronec-
tin, and proteoglycan and inhibits extracellular matrix degra-
dation [6]. It has been suggested that ¢broblasts activation
and proliferation are responsible for the overproduction of
TGF-L1 [7]. Angiotensin II is known to be implicated in the
development of myocardial ¢brosis and its action in cardiac
¢broblasts has been shown to stimulate the autocrine produc-
tion and release of TGF-L1 [8,9]. To date, only little informa-
tion exists regarding the identi¢cation of stimuli leading to the
proliferation of ¢broblasts.
Therefore, it was the aim of our study to test whether O32 is
able to induce both cardiomyocyte death and cardiac ¢bro-
blast proliferation and as such may be an important contrib-
utor to the development of the characteristic phenotype of
failing myocardium. In addition, the gene expression of
TGF-L1 was also detected in cardiac ¢broblasts in response
to superoxide stimulation.
2. Materials and methods
2.1. Materials
Xanthine oxidase, xanthine, hydrogen peroxide (H2O2), bovine
erythrocyte superoxide dismutase (SOD), bovine liver catalase and
anti-K-sarcomeric actin monoclonal antibody were purchased from Sig-
ma (St. Louis, MO, USA). Cell death detection ELISA kit was pur-
chased from Boehringer Mannheim (Germany). Dulbecco’s modi¢ed
Eagle medium F-12 was from Gibco. In situ apoptosis detection kit was
purchased from Oncor. Rat TGF-L1 cDNA probe was kindly provided
by Dr. Martin Stula (Humboldt-University, Berlin, Germany).
2.2. Cell cultures
Monolayer cultures of neonatal rat cardiac cells were prepared by
modi¢cations of the method described by Simpson et al. [10]. Brie£y,
hearts from 1-day old Wistar rats were dissected, minced, and placed
in PBS. The tissue was trypsinized at 37‡C in a HEPES-bu¡ered saline
solution: 20 mM HEPES-NaOH, pH 7.6, 130 mM NaCl, 3 mM KCl,
1 mM NaH2PO4, 4 mM glucose, 0.15% trypsin. Following centrifu-
gation, cells were resuspended in Dulbecco’s modi¢ed Eagle medium
F-12 containing 5% heat-inactivated horse serum, 100 WM ascorbate,
1 Wg/ml insulin, 1 Wg/ml transferrin, 10 ng/ml selenium, 100 U/ml
penicillin, 100 Wg/ml streptomycin. The dissociated cells were pre-
plated at 37‡C for 1 h and subsequently cultured for 62^72 h in
medium containing 0.1 mM bromodeoxyuridine to prevent prolifera-
tion of non-myocytes. These cells are hereafter referred to as cardio-
myocytes. More than 95% of cells were cardiomyocytes as detected by
immunostaining with the K-sarcomeric actin antibody.
In order to obtain cultures of cardiac ¢broblasts, cells adherent to
the culture dishes were cultured after preplating by adding the normal
culture medium except that 10% fetal calf serum was added and bro-
modeoxyuridine was omitted. Cells used for experiment were at pas-
sage level 4^6. In these passages more than 95% of cells were ¢bro-
blasts as detected by immunostaining with the ecto-5P11-nucleotidase
monoclonal antibody (a generous gift from B. Kaissling [11]). These
cells are hereafter referred to as cardiac ¢broblasts.
2.3. Exposure of cells to O32 generating system or to H2O2
Cultured cells were washed twice with Hanks’ balanced salt solution
(HBSS) at 37‡C. Washed cells were incubated at 37‡C for 1 h in
HBSS containing the indicated concentration of xanthine oxidase
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plus xanthine (XO/X) in the presence of catalase. H2O2 treatment was
performed under the same conditions. The reaction was stopped by
removing the HBSS containing the O32 generating system or H2O2.
The cells were further cultured for the indicated time in freshly pre-
pared culture medium as before treatment. When SOD or catalase
were used, they were added simultaneously with XO/X. Control cells
were treated under the same conditions without XO/X.
2.4. Analysis of DNA fragmentation
DNA fragmentation was analyzed by cell death detection ELISA.
ELISA was performed according to the manufacturer’s instructions.
Brie£y, the anti-histone monoclonal antibody was added to the 96-
well ELISA plates and incubated overnight at 4‡C. Following recoat-
ing, the cytoplasmic fractions were added and incubated for 90 min at
room temperature. Bound nucleosomes were detected by the addition
of an anti-DNA-peroxidase monoclonal antibody and reacted for
90 min at room temperature. After the addition of the substrate opti-
cal density was read with an ELISA reader at 405 nm.
2.5. In situ nick end-labeling and immuno£uorescence
The terminal deoxyribonucleotidyl transferase (TDT)-mediated
dUTP-digoxigenin nick end-labeling (TUNEL) assay was used to de-
tect DNA fragmentation in situ. The detection procedures were in
accordance with the kit instructions. Brie£y, cells were ¢xed in 4%
neutral bu¡ered formalin and subsequently incubated with TDT in
the presence of digoxigenin-conjugated dUTP for 1 h at 37‡C. After
the reaction was terminated the £uorescein-labeled anti-digoxigenin
antibody was incubated with samples for 30 min. Following the TU-
NEL procedure, samples were blocked by 1.4% bovine albumin for
30 min. Subsequently, the anti-K-sarcomeric actin monoclonal anti-
body and the anti-mouse Ig-rhodamine was incubated on the cover-
slip for 1 h at 37‡C.
2.6. Measurements of DNA synthesis and cell number
Cells were grown in 24-well plates with a seeding density at 2000/
cm2. When cells reached subcon£uence they were made quiescent for
48 h in 0.2% serum conditions. After treatment, cells were further
cultured for 24 h, and pulse-labeled with [3H]thymidine (1 WCi/ml)
for 1 h before the completion of the 24 h incubation period.
[3H]Thymidine incorporation into DNA was measured as trichloro-
acetic acid (TCA)-insoluble radioactivity as described previously with
slight modi¢cations [12]. Brie£y, cells were washed three times with
PBS, and then incubated with 15% TCA at 4‡C for 30 min. After
aspiration of TCA, cells were washed twice with distilled water. 1 M
NaOH was added for 20 min and neutralized with 1 M HCl. The
contents of the wells were placed in scintillation vials for counting.
For the determination of cell numbers, cells were cultured for 6 days
after treatment. The media were changed every 48 h. Cells were sus-
pended with trypsin/EDTA (0.05%/0.5 mM) and counted using a he-
mocytometer.
2.7. RNA isolation and Northern blot analysis
Total RNA isolation, prehybridization and hybridization were per-
formed as described elsewhere [13]. For chemiluminescent detection,
the membrane was blocked for 30 min in 2.5% blocking reagent. The
membrane was then incubated for 30 min with an anti-digoxigenin
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Fig. 1. O32 induces apoptosis in cardiac myocytes. A: Cell death was determined by trypan blue exclusion after cells were treated for 1 h with
di¡erent doses of XO plus 0.1 mM xanthine in the presence of 500 U/ml catalase and further cultured for another 7 h. Superoxide dismutase
(SOD) was at 1000 U/ml. *P6 0.05, compared to unstimulated control cells. B: Double staining of cardiac cells with TUNEL and K-sarcomer-
ic actin. Cells were treated for 1 h with 0.04 U XO/ml plus 0.1 mM xanthine in the presence of 500 U/ml catalase and further cultured for an-
other 7 h. TUNEL and immunostaining of cardiac myocytes were subsequently processed. Arrows indicate TUNEL-positive cardiomyocytes.
Original magni¢cation U400. C: Quantitation of apoptotic cells detected by TUNEL. For each concentration more than 300 cells were counted
within random ¢elds and divided by the number of TUNEL positive cells. *P6 0.05, compared to control. D: DNA fragmentation determined
by cell death ELISA. ELISA was processed after cells were exposed for 1 h to the indicated doses of XO plus 0.1 mM xanthine in the presence
of 500 U/ml catalase and further cultured in medium for 7 h. Superoxide dismutase (SOD) was at 1000 U/ml. The histone-associated DNA
fragments are presented as the optical density at 405 nm. *P6 0.05, compared to control.
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antibody conjugated with alkaline phosphatase. Following two
washes with 100 mM maleic acid bu¡er containing 0.3% Tween-20,
CSPD substrate solution was added to the membrane and incubated
for 10 min. The membrane was wrapped in plastic and exposed to
¢lm.
2.8. Statistical analysis
The results are expressed as means þ S.E.M. of at least three inde-
pendent experiments, unless stated otherwise. Data were evaluated by
Student’s t-test. A value of P6 0.05 was considered signi¢cant.
3. Results
3.1. O32 induces apoptosis in cardiomyocytes
XO/X was used to produce O32 , since XO/X yields both O
3
2
and H2O2, the H2O2-scavenger catalase was employed simul-
taneously to decompose H2O2. As can be seen from Fig. 1A,
XO/X in the presence of catalase could signi¢cantly induce
dose-dependent increases in the percentage of dead cardiac
cells. Addition of SOD almost completely prevented cell death
caused by XO/X plus catalase. XO, xanthine, SOD and cata-
lase alone had no e¡ect on the cell death (data not shown).
These data suggest that O32 is able to induce death in cardi-
omyocytes.
In order to test whether cell death caused by O32 occurred
by apoptosis, we employed TUNEL and cell death ELISA to
characterize apoptosis. As shown in Fig. 1B, after treatment
with XO/X plus catalase cell nuclei were labeled by in situ
(TUNEL) and identi¢ed as cardiomyocytes by staining for
K-sarcomeric actin. Taking those cells as apoptotic cardio-
myocytes, which simultaneously exhibited positive staining
for TUNEL and K-sarcomeric actin, apoptotic cells were
counted and the results are depicted in Fig. 1C. O32 caused
dose-dependent increases in the percentage of apoptotic cells.
We next employed a cell death detection ELISA, which
speci¢cally detects histone-associated DNA-fragments within
the cytoplasmic fraction of stimulated cells and which includes
those cells £oating in the medium of the culture dishes after
treatment. As can be seen from Fig. 1D, there was a dose-
dependent gradual increase of oligonucleosomes in the cyto-
plasmic fraction after treatment with XO/X in the presence of
catalase. Administration of SOD could almost completely ab-
rogate XO/X plus catalase-induced DNA fragmentation in
cardiomyocytes. Taken together, these data suggest that O32
is able to induce apoptosis in cardiomyocytes.
3.2. O32 induces proliferation of cardiac ¢broblasts
To test whether cardiac ¢broblasts might also undergo
apoptosis when exposed to O32 under the same conditions as
cardiomyocytes, we ¢rst detected if cardiac ¢broblasts under-
went cell death after exposed to O32 . As illustrated in Fig. 2A,
7 h after treatment with increasing doses of XO/X in the
presence of catalase there was no signi¢cant increase in the
percentage of dead cells in cardiac ¢broblasts. Concomitantly,
the cells were negative to TUNEL, and there was no marked
increase in DNA fragmentation (data not shown). These data
indicate that cardiac ¢broblasts do not undergo apoptosis in
response to O32 stimulation.
In light of the distinct characteristics between cardiomyo-
cytes and cardiac ¢broblasts in which myocytes are terminally
di¡erentiated whereas ¢broblasts are able to proliferate, we
reasoned that ¢broblasts might undergo proliferation in re-
sponse to O32 stimulation, as we had previously observed in
vascular smooth muscle cells [13]. To test this hypothesis,
after treatment with O32 we analyzed cell proliferation by us-
ing [3H]thymidine incorporation to detect DNA synthesis and
by counting cell number. Exposure of cardiac ¢broblasts to
XO/X in the presence of catalase resulted in increases of
[3H]thymidine incorporation (Fig. 2B) as well as cell number
(Fig. 2C), while the administration of SOD abolished XO/X
plus catalase-induced increases in DNA-synthesis and cell
number. XO, xanthine, SOD and catalase alone had no e¡ect
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Fig. 2. E¡ect of O32 on death and proliferation of cardiac ¢bro-
blasts. A: Cell death was determined by trypan blue exclusion after
cells were treated for 1 h with di¡erent doses of XO plus 0.1 mM
xanthine in the presence of 500 U/ml catalase and further cultured
for another 7 h in the presence of 10% fetal calf serum (FCS).
B: [3H]Thymidine incorporation. Cardiac ¢broblasts were exposed
to di¡erent doses of XO plus 0.1 mM xanthine in the presence of
500 U/ml catalase. Superoxide dismutase (SOD) was at 1000 U/ml.
Cardiac ¢broblasts in 10% FCS served as positive control.
*P6 0.05, compared to control. C: Cell counting. Cell number was
counted 6 days after treatment. *P6 0.05, compared to control.
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on [3H]thymidine incorporation and cell number (data not
shown). Thus, cardiac ¢broblasts underwent proliferation in
response to O32 stimulation.
H2O2 is the product of O32 dismutation. To test if H2O2
serves as a mediator of O32 in the induction of cell prolifer-
ation, we exposed cardiac ¢broblasts to H2O2 which is known
to easily penetrate cell membranes. As shown in Fig. 3 H2O2
caused cell death rather than proliferation, excluding the pos-
sibility that H2O2 is involved in the signal pathway of O32 .
3.3. TGF-L1 is upregulated in cardiac ¢broblasts in response to
O32 stimulation
Since it has been shown that cardiac ¢broblasts are able to
produce TGF-L1 [8,9] a growth factor which is involved in
cardiac ¢brosis, this led us to test whether O32 can stimulate
the gene expression of TGF-L1. As shown in Fig. 4, XO/X in
the presence of catalase led to time-dependent increases in
TGF-L1 gene expression, and such increases could be abro-
gated by the addition of SOD. XO, xanthine, catalase and
SOD alone had no e¡ect on TGF-L1 expression (data not
shown). These data suggest that in cardiac ¢broblasts TGF-
L1 is upregulated upon O32 stimulation.
4. Discussion
It appears that the O32 -induced spectrum of cellular alter-
ations is broad and in fact may include such divergent e¡ects
as cell growth and cell death depending largely on the a¥icted
cell type. This notion is supported by our present data reveal-
ing that under the same stimulation with O32 two types of
cardiac cells behave di¡erently with apoptosis occurring in
cardiomyocytes and proliferation occurring in cardiac ¢bro-
blasts.
The present observation of the apoptotic e¡ect of O32 on
cardiomyocytes, a terminally di¡erentiated cell type, is consis-
tent with a study performed on another type of postmitotic
cells, neurons, where scavenging of O32 by overexpression of
Cu/Zn-superoxide dismutase delays apoptosis in neuronal
cells deprived of nerve growth factor [14]. Also, O32 can me-
diate staurosporine-induced apoptosis of hippocampal neu-
rons [15]. It is not yet clear how O32 initiates the apoptotic
program. There is evidence showing that mitochondria play a
pivotal role in apoptosis by releasing cytochrome c [16,17] or
by the opening of mitochondrial membrane transition [18,19].
It is unlikely that cytochrome c participates in O32 -induced
cardiomyocyte apoptosis because it is not released upon O32
stimulation (our unpublished data). Overexpression of man-
ganese superoxide dismutase restored mitochondrial trans-
membrane potential, suggesting a possible link between O32
and mitochondrial integrity [20]. Whether O32 is able to in-
duce mitochondrial membrane transition in cardiomyocytes
remains to be elucidated.
The failure of O32 to induce apoptosis in cardiac ¢broblasts
indicates the existence of cell type speci¢c di¡erences in the
response to O32 . This is in agreement with other observations.
For example, O32 , which is generated by XO/X, prevents Fas-
mediated apoptosis in di¡erent tumor cell lines [21]. Vascular
smooth muscle cells are stimulated to proliferate by O32
[13,22]. On the other hand, O32 can play a role in mediating
growth signals. O32 mediates cell proliferation stimulated by
lactosylceramide [23] or by serotonin [24] via activation of the
kinase cascade in smooth muscle cells. However, not all mi-
totic cell types proliferate in response to O32 . Instead, O
3
2 can
be a mediator to trigger the execution of apoptosis in mitotic
cells. O32 is able to convey death signals of growth factor
deprivation in apoptosis of proximal tubular cells [25]. In
addition, O32 interacts with nitric oxide to form peroxynitrite,
which has been shown to induce apoptosis in several types of
cells [26,27].
Although there is evidence showing that there is a link
between oxidative stress and the development of heart failure
[2,3], it is unclear how oxidative stress contributes to this
disease. Our data provide strong evidence indicating that
O32 could be a potential factor involved in the development
of the well characterized phenotype of the failing heart con-
sisting of cardiomyocyte death and interstitial ¢brosis.
It has been shown that myocardial ischemia/reperfusion is
accompanied by a signi¢cant increase in the expression TGF-
L1 [28,29]. Because ischemia/reperfusion leads to the forma-
tion of O32 , our data that O
3
2 is able to upregulate the gene
expression of TGF-L1 in cardiac ¢broblasts may provide a
link between ischemia/reperfusion and TGF-L1 expression.
In our present work TGF-L1 was upregulated in cardiac
¢broblasts by the direct stimulation with O32 . It would be of
interest to study if O32 can be a signaling mediator for growth
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Fig. 4. E¡ect of O32 on TGF-L1 expression analyzed by Northern
blot. Cardiac ¢broblasts were exposed to XO at 0.04 U/ml plus
0.1 mM xanthine in the presence of 500 U/ml catalase. Superoxide
dismutase (SOD) was at 1000 U/ml. Total RNA was isolated from
cells at the indicated time. Relative amounts of mRNA were nor-
malized by rat GAPDH mRNA. One representative blot from three
independent experiments is shown.
Fig. 3. E¡ect of H2O2 on the viability of cardiac ¢broblasts assessed
by trypan blue exclusion. Cells were treated for 1 h with di¡erent
doses of H2O2 and further cultured in H2O2-free medium for 7 h.
*P6 0.05, compared to control.
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factors like angiotensin II in stimulating the pathogenesis of
myocardial ¢brosis.
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